¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"J Drug Target"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
accommodative target
Á¶ÀýÀ¯¹ß½ÃÇ¥
source-target distance
¿øÃµÇ¥Àû»çÀ̰Ÿ®, ¿øÃµÇ¥Àû°£°Å¸®
target
1. Ç¥Àû 2. Ç¥Àû¼¼Æ÷
target cell
Ç¥Àû¼¼Æ÷
target cell anemia
Ç¥Àû¼¼Æ÷ºóÇ÷
target configuration
°ú³á¸ð¾ç, Ç¥Àû¸ð¾ç
target gland
Ç¥Àû»ù, Ç¥Àû¼±
target lesion
Ç¥Àûº´ÅÍ
target organ
Ç¥ÀûÀå±â
target population
Ç¥ÀûÁý´Ü
target sign
Ç¥Àû¡ÈÄ
target skin distance
Ç¥ÀûÇǺΰŸ®
antiallergic drug
¾Ë·¹¸£±â¾à, Ç׾˷¹¸£±âÁ¦
antiamebic drug
¾Æ¸Þ¹Ù¾à, Ç׾Ƹ޹ÙÁ¦
antianxiety drug
Ç׺ҾÈÁ¦, ºÒ¾ÈÄ¡·áÁ¦
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
target cell
Ç¥Àû¼¼Æ÷
target organ
Ç¥ÀûÀå±â
drug
¾à, ¾à¹°, ¾àÁ¦
antiamebic drug
¾Æ¸Þ¹Ù¾à, Ç׾Ƹ޹ÙÁ¦
antiarrhythmic drug
ºÎÁ¤¸Æ¾à, Ç׺ÎÁ¤¸ÆÁ¦
anticoagulant drug
Ç×ÀÀ°íÁ¦
antiemetic drug
±¸Åä¾à, Ç×±¸ÅäÁ¦
antihistaminic drug
Ç×È÷½ºÅ¸¹ÎÁ¦
antihypertensive drug
°íÇ÷¾Ð¾à, Ç×°íÇ÷¾ÐÁ¦
antimalarial drug
¸»¶ó¸®¾Æ¾à, Ç׸»¶ó¸®¾ÆÁ¦
antiplatelet drug
Ç×Ç÷¼ÒÆÇÁ¦
antiseizure drug
°æ·Ã¾à, Ç×°æ·ÃÁ¦
antiseptic drug
Ç×±Õ¾à
antituberculosis drug
°áÇÙ¾à, Ç×°áÇÙÁ¦
antiviral drug
¹ÙÀÌ·¯½º¾à, Ç×¹ÙÀÌ·¯½ºÁ¦
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
accommodative target
Á¶ÀýÀ¯¹ß½ÃÇ¥
target cell anemia
Ç¥ÀûÀûÇ÷±¸ºóÇ÷
clinical target volume
ÀÓ»óÇ¥ÀûüÀû
target cell
Ç¥Àû¼¼Æ÷
target configuration
°ú³á¸ð¾ç, Ç¥Àû¸ð¾ç
source-target distance
¼±¿øÇ¥Àû°£°Å¸®
target skin distance
Ç¥ÀûÇǺΰŸ®
target gland
Ç¥Àû»ù
target lesion
Ç¥Àûº´ÅÍ
target organ
Ç¥ÀûÀå±â
planning target volume
°èȹǥÀûºÎÇÇ
target population
Ç¥ÀûÁý´Ü
target skin distance radiation
Ç¥ÀûÇǺΰŸ®¹æ»ç¼±
target sign
Ç¥Àû¡ÈÄ
target
Ç¥Àû
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
OTC drug : over-the-counter drug
ÀϹݸžà.
accommodative target
Á¶ÀýÀ¯¹ß½ÃÇ¥
fusional target
À¶ÇÕÇ¥Áö
planning target volume
°èȹ¿ë Ç¥ÀûºÎÇÇ
radiation,target theory of
¡ÀÇ Ç¥ÀûÀÌ·Ð(¡øöîÜìµÖå)
ADR : adverse drug reaction
¾à¹°À¯ÇØÀÛ¿ë(å·ÚªêóúªíÂéÄ).
IND : investigational new drug
½ÃÇè¿ë½Å¾à.
Langmuir expression in drug-antibody binding
¾à¹°-Ç×ü °áÇÕ¿¡¼ÀÇ ¶û¹¿¸£Ç¥Çö
NDA : new drug application
½Å¾àÇã°¡½Åû.
TDM : therapeutic drug monitoring
Ä¡·á¾à¹°³óµµ ¸ð´ÏÅ͸µ.
addiction, drug
¸¶¾à»ó½À(ئå·ßÈã§)
adrenergic stimulating drug
¾Æµå·¹³¯¸°ÈïºÐ¾à, ¾Æµå·¹³¯¸°ÀÚ±ØÁ¦.
adulterated drug
¼¯À½Áú¾àǰ.[¿¹¹æ]ºÎÁ¤¾àǰ(ËÓËøËâ̰).
allergy, drug
¾à¹°¾Ë·¹¸£±â
antiallergic agent =a. drug
Ç׾˷¹¸£±â¾à.
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
drug dependence ; drug dependency
¾à¹°ÀÇÁ¸(¼º).
accommodative target
Á¶ÀýÀ¯¹ß½ÃÇ¥
cell, target
Ç¥Àû¼¼Æ÷
clinical target volume, CTV
ÀÓ»óÇ¥ÀûüÀû
codocyte= target cell
Ç¥Àû¼¼Æ÷
fusional target
À¶ÇÕÇ¥Áö
leptocytes = target cell
Ç¥Àû»óÀûÇ÷±¸= Ç¥Àû¼¼Æ÷
maximum target dose
ÃÖ°íÇ¥Àû¼±·®
mean target dose
Æò±ÕÇ¥Àû¼±·®
median target absorbed dose
Áß¾ÓÇ¥ÀûÈí¼ö¼±·®
median target dose
Áß¾ÓÇ¥Àû¼±·®
minimum target dose
ÃÖ¼ÒÇ¥Àû¼±·®
modal target dose
ÃÖºóÇ¥Àû¼±·®
planning target volume
°èȹ¿ë Ç¥ÀûºÎÇÇ
radiation,target theory of
¡ÀÇ Ç¥ÀûÀÌ·Ð(¡øöîÜìµÖå)
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½